Abbexa Ltd's Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody is a Polyclonal antibody. This antibody has been shown to work in applications such as: Immunocytochemistry, Immunofluorescence, Immunohistochemistry, and Western Blot. The Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody was generated using PRAME, and PRAME nuclear receptor transcriptional regulator as the antigen and it reacts with Homo Sapiens, and Human.
Description
Polyclonal Antibody to Melanoma Antigen Preferentially Expressed In Tumors (PRAME)